Notable Doping Cases in Powerlifting and What They Changed
Few strength sports have a history as entangled with performance-enhancing drugs as powerlifting. Doping cases have split federations, redrawn the US competitive landscape and changed how lifters think about supplements. Rather than retell rumors about individuals, our editors focus on documented patterns and institutional cases, and on what they mean for lifters today.
Why powerlifting is especially exposed
Powerlifting tests maximal strength in the squat, bench press and deadlift. Maximal strength responds strongly to androgens, and anabolic steroids were already widespread in strength sports when organized powerlifting took shape in the 1960s and 1970s.
Research on lifters illustrates this connection. Swedish studies of elite powerlifters compared athletes with and without long-term anabolic steroid use and found differences in muscle fiber size and the number of nuclei per fiber, showing how deeply these drugs can alter muscle tissue.
The sport's structure also mattered. Unlike Olympic weightlifting, powerlifting was never part of the Olympic program, so it was not covered by IOC anti-doping rules for most of its history. Testing depended entirely on each federation's own policies and resources.
The result was a patchwork. Some organizations embraced testing early, while others chose not to test at all, a choice that still defines the sport today.
The great split: tested versus untested federations
The International Powerlifting Federation (IPF), founded in 1972, introduced drug testing at its international championships in the early 1980s. Positive tests among top lifters soon followed, and they shocked a sport that had operated largely without checks.
Testing provoked a backlash. Lifters and organizers who objected to testing or to how it was implemented created alternative federations. Over the following decades, the US in particular developed dozens of federations, some fully tested, some partially tested and many untested.
Alongside this, explicitly drug-free federations appeared, promoting lifetime drug-free requirements and sometimes polygraph testing in addition to urinalysis.
This split means that comparing records across federations is often meaningless. A total set in an untested meet is not directly comparable to one set under WADA-compliant testing.
Recurring patterns in sanctions
Published anti-doping sanction lists from tested federations reveal consistent patterns. Rather than single dramatic cases, they show which substance classes appear repeatedly.
| Substance class | Examples found in sanctions | Comment |
|---|---|---|
| Anabolic steroids | Stanozolol, metandienone, nandrolone, trenbolone | Most common category historically |
| SARMs | Ostarine (enobosarm), LGD-4033 | Rising since the 2010s; often in mislabeled products |
| Hormone and metabolic modulators | Tamoxifen, clomiphene, letrozole | Often used to counter steroid side effects |
| Diuretics and masking agents | Furosemide, hydrochlorothiazide | Weight cutting or masking |
| Stimulants | Methylhexaneamine (DMAA) | Frequently from pre-workout products |
| Metabolic agents | Meldonium | Many positives across sports after its 2016 ban |
The prominence of SARMs and stimulants highlights a modern problem: some positive tests trace back to supplements that contained undeclared drugs. Under the strict liability principle of the World Anti-Doping Code, athletes remain responsible for whatever is found in their samples.
Out-of-competition testing and long-term sample storage have increased the number of cases. Samples can be reanalyzed for years using improved methods, a deterrent that did not exist in the sport's early decades.
Institutional cases: teams and federations
Some of powerlifting's most consequential cases involved organizations rather than individuals. Under IPF rules, national federations whose athletes accumulate multiple anti-doping violations within a set period can face fines or suspensions, meaning a whole country's lifters may be barred from international competition.
Such sanctions push national federations to invest in education and domestic testing. They also create pressure within teams, since one athlete's violation can affect everyone.
The most significant recent institutional development in the US came in 2021. After a dispute that centered in part on anti-doping procedures and testing arrangements, the IPF ended its relationship with USA Powerlifting, the long-standing American affiliate, and later recognized a new national affiliate, Powerlifting America.
For American lifters, this reshaped the route to international IPF competition and underscored how much anti-doping governance determines a federation's standing. The episode shows that doping policy is not only about individual sanctions but about the legitimacy of entire organizations.
Health and legal context for lifters
Beyond sport rules, anabolic steroids are Schedule III controlled substances under US federal law, and possession without a prescription is a crime. SARMs are not approved by the FDA for any use, and the agency has warned consumers about products containing them.
Health consequences are a central part of the picture. Long-term steroid use has been linked to cardiomyopathy, adverse lipid changes, suppression of natural testosterone production, infertility and psychiatric effects. These harms persist regardless of whether a lifter competes in a tested or untested federation.
- Check your federation's anti-doping rules and testing program before competing.
- Use only third-party certified supplements if you compete in tested meets.
- Apply for a therapeutic use exemption (TUE) before using any prescribed medication on the Prohibited List.
- Keep records of all products and medications you take.
The athlete biological passport, which tracks blood and steroid markers over time, is increasingly used in tested sport. It allows violations to be identified even without a single positive test.
Editorial Team Conclusions
Doping has shaped powerlifting's structure more than almost any other sport, splitting it into tested and untested federations.
Sanction lists show recurring use of steroids, SARMs, anti-estrogens, diuretics and stimulants, with contaminated supplements an ongoing risk.
Institutional cases, including the 2021 split between the IPF and USA Powerlifting, demonstrate that anti-doping governance determines a federation's international standing.
You may also want to read our articles on the WADA Prohibited List explained, how the athlete biological passport works, and the risks of SARMs.
References
- Eriksson A, Kadi F, Malm C, Thornell LE. Skeletal muscle morphology in power-lifters with and without anabolic steroids. Histochem Cell Biol. 2005;124(2):167–175.
- Yu JG, Bonnerud P, Eriksson A, Stål PS, Tegner Y, Malm C. Effects of long term supplementation of anabolic androgen steroids on human skeletal muscle. PLoS One. 2014;9(9):e105330.
- Kanayama G, Pope HG Jr. History and epidemiology of anabolic androgens in athletes and non-athletes. Mol Cell Endocrinol. 2018;464:4–13.
- Pope HG Jr, Wood RI, Rogol A, et al. Adverse health consequences of performance-enhancing drugs: an Endocrine Society scientific statement. Endocr Rev. 2014;35(3):341–375.
- Sottas PE, Robinson N, Rabin O, Saugy M. The athlete biological passport. Clin Chem. 2011;57(7):969–976.
- World Anti-Doping Agency. World Anti-Doping Code 2021. Montreal: WADA; 2021.
- https://anabolicstoreja.net/
